title: Neglected diseases see few new drugs despite upped investment.
authors.forename: Cassandra
authors.initials: C
authors.lastname: Willyard
mesh_terms: D002202:Capital Financing; D017277:Drug Approval / Q000191:economics* / Q000706:statistics & numerical data*; D055808:Drug Discovery; D004345:Drug Industry; D006801:Humans; D058069:Neglected Diseases / Q000188:drug therapy*